Dalotuzumab (Synonyms: MK-0646; h7C10) |
| Catalog No.GC26322 |
Dalotuzumab (MK-0646) is a recombinant humanized monoclonal antibody (IgG1 type) targeting IGF-1R. Dalotuzumab works by inhibiting IGF-1 and IGF-2 mediated tumor cell proliferation, IGF-1R autophosphorylation, and Akt phosphorylation.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1005389-60-5
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Dalotuzumab (MK-0646) is a recombinant humanized monoclonal antibody (IgG1 type) targeting IGF-1R. Dalotuzumab works by inhibiting IGF-1 and IGF-2 mediated tumor cell proliferation, IGF-1R autophosphorylation, and Akt phosphorylation. Dalotuzumab can also induce cell apoptosis and cycle arrest. Dalotuzumab can enhance its in vitro and in vivo anti-tumor activity when used in combination with other anticancer active molecules, such as statin like molecules.
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *